Tetiana Kosten is the founder and director of Atain. She established the consultancy in 2020, supporting investors through the fast-paced post-pandemic investment surge and has been successfully operating in the market ever since.

Tetiana has 10 years of professional consulting experience  specialising in investment due diligence and strategy and developed a strong interest in healthcare investments while working at Roland Berger in Munich. Her approach to due diligence incorporates proprietary knowledge and deep expertise of the life sciences ecosystem, addressing investors’ requirements for both mature and early-stage companies.

Tetiana holds an MSc in Biotechnology from Shevchenko University in Kyiv and a PhD from the Max Delbrück Center and Free University in Berlin. She speaks Ukrainian, English, and German and is committed to promoting women’s entrepreneurship.